Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498446 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging of Atrial Septal Defects
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 44
- Enrollment target
NCT00498446: Completed study, sponsored by Duke University.
NCT00498446 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498446 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
An atrial septal defect (ASD) is a hole in the heart that can lead to heart failure. Depending on the size and severity of the ASD, They can be treated during a heart catheterization with a special device that can permanently seal the ASD, but knowing the exact size and severity of the ASD is crucial. Newer MRI techniques may provide a better way at diagnosing the size and severity of an ASD. We compared MRI to other standard clinical ways for evaluating an ASD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-07 |
What the finished NCT00498446 record still lists
NCT00498446 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00498446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00498446 about?
NCT00498446 is a clinical study titled "Magnetic Resonance Imaging of Atrial Septal Defects". An atrial septal defect (ASD) is a hole in the heart that can lead to heart failure. Depending on the size and severity of the ASD, They can be treated during a heart catheterization with a special device that can permanently seal the ASD, but knowing the exact size and severity of the ASD is crucia...
What is the current status of trial NCT00498446?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2002-07. Estimated completion is 2004-07.
Who is sponsoring clinical trial NCT00498446?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia